Prevalent and Incident Tuberculosis Are Independent Risk Factors for Mortality among Patients Accessing Antiretroviral Therapy in South Africa

被引:48
|
作者
Gupta, Ankur [1 ]
Wood, Robin [2 ]
Kaplan, Richard [2 ]
Bekker, Linda-Gail [2 ]
Lawn, Stephen D. [1 ,2 ]
机构
[1] London Sch Hyg & Trop Med, Dept Clin Res, Fac Infect & Trop Dis, London WC1, England
[2] Univ Cape Town, Desmond Tutu HIV Ctr, Inst Infect Dis & Mol Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa
来源
PLOS ONE | 2013年 / 8卷 / 02期
基金
美国国家卫生研究院; 英国惠康基金;
关键词
HIV-ASSOCIATED TUBERCULOSIS; IMMUNE RECONSTITUTION DISEASE; SUB-SAHARAN AFRICA; PULMONARY TUBERCULOSIS; TREATMENT PROGRAM; INFECTED PATIENTS; EARLY OUTCOMES; RURAL UGANDA; ADULTS; DETERMINANTS;
D O I
10.1371/journal.pone.0055824
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Patients with prevalent or incident tuberculosis (TB) in antiretroviral treatment (ART) programmes in sub-Saharan Africa have high mortality risk. However, published data are contradictory as to whether TB is a risk factor for mortality that is independent of CD4 cell counts and other patient characteristics. Methods/Findings: This observational ART cohort study was based in Cape Town, South Africa. Deaths from all causes were ascertained among patients receiving ART for up to 8 years. TB diagnoses and 4-monthly CD4 cell counts were recorded. Mortality rates were calculated and Poisson regression models were used to calculate incidence rate ratios (IRR) and identify risk factors for mortality. Of 1544 patients starting ART, 464 patients had prevalent TB at baseline and 424 developed incident TB during a median of 5.0 years follow-up. Most TB diagnoses (73.6%) were culture-confirmed. A total of 208 (13.5%) patients died during ART and mortality rates were 8.84 deaths/100 person-years during the first year of ART and decreased to 1.14 deaths/100 person-years after 5 years. In multivariate analyses adjusted for baseline and time-updated risk factors, both prevalent and incident TB were independent risk factors for mortality (IRR 1.7 [95% CI, 1.2-2.3] and 2.7 [95% CI, 1.9-3.8], respectively). Adjusted mortality risks were higher in the first 6 months of ART for those with prevalent TB at baseline (IRR 2.33; 95% CI, 1.5-3.5) and within the 6 months following diagnoses of incident TB (IRR 3.8; 95% CI, 2.6-5.7). Conclusions: Prevalent TB at baseline and incident TB during ART were strongly associated with increased mortality risk. This effect was time-dependent, suggesting that TB and mortality are likely to be causally related and that TB is not simply an epiphenomenon among highly immunocompromised patients. Strategies to rapidly diagnose, treat and prevent TB prior to and during ART urgently need to be implemented.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] A systematic review of risk factors for mortality among tuberculosis patients in South Africa
    Tamaryn J Nicholson
    Graeme Hoddinott
    James A Seddon
    Mareli M Claassens
    Marieke M van der Zalm
    Elisa Lopez
    Peter Bock
    Judy Caldwell
    Dawood Da Costa
    Celeste de Vaal
    Rory Dunbar
    Karen Du Preez
    Anneke C Hesseling
    Kay Joseph
    Ebrahim Kriel
    Marian Loveday
    Florian M Marx
    Sue-Ann Meehan
    Susan Purchase
    Kogieleum Naidoo
    Lenny Naidoo
    Fadelah Solomon-Da Costa
    Rosa Sloot
    Muhammad Osman
    Systematic Reviews, 12
  • [2] A systematic review of risk factors for mortality among tuberculosis patients in South Africa
    Nicholson, Tamaryn J.
    Hoddinott, Graeme
    Seddon, James A.
    Claassens, Mareli M.
    van der Zalm, Marieke M.
    Lopez, Elisa
    Bock, Peter
    Caldwell, Judy
    Da Costa, Dawood
    de Vaal, Celeste
    Dunbar, Rory
    Du Preez, Karen
    Hesseling, Anneke C.
    Joseph, Kay
    Kriel, Ebrahim
    Loveday, Marian
    Marx, Florian M.
    Meehan, Sue-Ann
    Purchase, Susan
    Naidoo, Kogieleum
    Naidoo, Lenny
    Solomon-Da Costa, Fadelah
    Sloot, Rosa
    Osman, Muhammad
    SYSTEMATIC REVIEWS, 2023, 12 (01)
  • [3] Tuberculosis risk factors and mortality for HIV-infected persons receiving antiretroviral therapy in South Africa
    Komati, Stephanus
    Shaw, Pamela A.
    Stubbs, Nomso
    Mathibedi, Monkwe J.
    Malan, Lizette
    Sangweni, Phumelele
    Metcalf, Julia A.
    Masur, Henry
    Hassim, Shaheen
    AIDS, 2010, 24 (12) : 1849 - 1855
  • [4] Screening for active tuberculosis among patients accessing antiretroviral therapy in sub-Saharan Africa
    Lawn, Stephen D.
    Kranzer, Katharina
    Edwards, David J.
    Wood, Robin
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2009, 13 (09) : 1186 - 1187
  • [5] Screening for active tuberculosis among patients accessing antiretroviral therapy in sub-Saharan Africa Reply
    Were, Willy
    Moore, David
    Kaharuza, Frank
    Ekwaru, Paul
    Mwima, Gerald
    Bunnell, Rebecca
    Rutherford, George
    Mermin, Jonathan
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2009, 13 (09) : 1187 - 1188
  • [6] Convergence of Mortality Rates among Patients on Antiretroviral Therapy in South Africa and North America
    Binagwaho, Agnes
    Nutt, Cameron T.
    Mugwaneza, Placidie
    Wagner, Claire M.
    Nsanzimana, Sabin
    PLOS MEDICINE, 2014, 11 (09)
  • [7] Risk Factors Associated with Increased Mortality among HIV Infected Children Initiating Antiretroviral Therapy (ART) in South Africa
    Zanoni, Brian C.
    Phungula, Thuli
    Zanoni, Holly M.
    France, Holly
    Feeney, Margaret E.
    PLOS ONE, 2011, 6 (07):
  • [8] Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy
    Manosuthi, Weerawat
    Chottanapand, Suthat
    Thongyen, Supeda
    Chaovavanich, Achara
    Sungkanuparph, Somnuek
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 43 (01) : 42 - 46
  • [9] Hopes interrupted: accessing and experiences of antiretroviral therapy in South Africa
    Fried, Jana
    Harris, Bronwyn
    Eyles, John
    SEXUALLY TRANSMITTED INFECTIONS, 2012, 88 (02) : 147 - 151
  • [10] Factors associated with prevalent tuberculosis among patients receiving highly active antiretroviral therapy in a Nigerian tertiary hospital
    Iroezindu, M. O.
    Ofondu, E. O.
    Mbata, G. C.
    van Wyk, B.
    Hausler, H. P.
    Au, D. H.
    Lynen, L.
    Hopewell, P. C.
    ANNALS OF MEDICAL AND HEALTH SCIENCES RESEARCH, 2016, 6 (02) : 120 - 128